Wird geladen...
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
Background: Doxorubicin (DOX), a broad-spectrum chemotherapy drug, is clinically employed to treat cancers especially for breast cancer and lung cancer. But its clinical applications are limited by the dose-dependent cardiac toxicity. Resveratrol (Res), a polyphenolic antitoxin, has been proved to b...
Gespeichert in:
| Veröffentlicht in: | Int J Nanomedicine |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681569/ https://ncbi.nlm.nih.gov/pubmed/31534336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S211130 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|